Released May 9, 2023, after the close
10-Q filed May 10, 2023, 40 days after period end · 0001636422-23-000058
Q1 2023 · 10-Q
Revenue$73.87M$73.87M +8.5% vs Q1 2022+6.8% vs Q4 2022
Net Income-$33.19M-$33.19M N/M vs Q1 2022N/M vs Q4 2022
EPS Diluted-$0.60-$0.60 N/M vs Q1 2022no prior Q4 2022 on file
Operating Income-$34,914,000N/M
Operating Cash Flow-$5,580,000N/M
Free Cash Flowderived-$6,005,000N/M
Margins · derived
Operating margin-47.3%−11.5 pt vs Q1 2022
Net margin-44.9%−11.9 pt vs Q1 2022
What the release said
The release
Same quarter
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $73.87M | $68.09M | $55.85M | $45.12M |
| Net Income | -$33.19M | -$22.46M | -$28.37M | -$17.49M |
| EPS Diluted | -$0.60 | -$0.54 | -$0.65 | -$0.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR